About
Precision Biosciences Inc (NASDAQ:DTIL) — investor relations, events, news, and company updates on 6ix.
Latest News
Yesterday
Precision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting
Apr 22 2026
Precision BioSciences Announces Late-Breaking Poster Presentation for PBGENE-HBV at European Association for the Study of the Liver Congress 2026
Apr 15 2026
Precision BioSciences Expands ELIMINATE-B Trial Following Clinical Trial Application Approval in Two European Countries
Apr 8 2026
Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference
Mar 12 2026
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Business Update
Financials
Revenue
$34.26 M
Market Cap
$170.56 M
EPS
-3.63
